CA215 and GnRH receptor as targets for cancer therapy
CA215 and GnRH receptor as targets for cancer therapy
About this item
Full title
Author / Creator
Lee, Gregory , Cheung, Anthony P. , Ge, Bixia , Zhu, Mingang , Giolma, Brett , Li, Bo , Wong, Eric , Li, Yu , Wang, Yu , Chen, Zinan and Gu, Jiang
Publisher
Berlin/Heidelberg: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Two monoclonal antibodies (Mabs), RP215 and GHR106, were selected for the preclinical evaluations of anti-cancer drugs targeting various human cancers including those of the ovary, cervix, lung, and liver. Both Mabs were shown to react with pan cancer markers, which are over-expressed on the surface of almost all human cancers. RP215 Mab was shown...
Alternative Titles
Full title
CA215 and GnRH receptor as targets for cancer therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11028410
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11028410
Other Identifiers
ISSN
0340-7004
E-ISSN
1432-0851
DOI
10.1007/s00262-012-1230-8
